Abstract
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
MeSH terms
-
Adrenergic alpha-Antagonists / therapeutic use
-
Aged
-
Finasteride / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Prostate / pathology
-
Prostate / physiology
-
Prostatectomy
-
Prostatic Hyperplasia* / diagnosis
-
Prostatic Hyperplasia* / physiopathology
-
Prostatic Hyperplasia* / therapy
-
Randomized Controlled Trials as Topic
-
Urinary Bladder / metabolism
-
Urination
-
Urination Disorders
Substances
-
Adrenergic alpha-Antagonists
-
Finasteride